Watchlist Price Alert

Hillstream BioPharma Inc. (HILS)

NASDAQ: HILS · Real-Time Price · USD

0.24

0.02 (7.00%)

At close: Sep 22, 2023, 7:59 PM

Hillstream BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Dec 31, 2020
Cash & Equivalents	2.69M	3.9M	3.57M	6.51M	7.6M	9.48M	11.12M	4.36K	45.09K	29.27K	191.85K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	477.89K	695.38K	1.15M	178.09K	235.95K	301.37K	233.18K	617.32K	3.87K	5.05K	102.95K
Total Current Assets	3.17M	4.6M	4.72M	6.69M	7.83M	9.79M	11.36M	621.68K	414.89K	283.13K	294.8K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	3.17M	4.6M	4.72M	6.69M	7.83M	9.79M	11.36M	621.68K	414.89K	283.13K	294.8K
Account Payables	1.14M	1.14M	718.99K	954.5K	536.84K	559.53K	597.46K	1.46M	1.21M	1.04M	514.83K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	697.84K	658.43K	463.6K	321.84K
Short-Term Debt	n/a	n/a	559.92K	n/a	n/a	n/a	n/a	1.39M	1.22M	646.48K	563.42K
Other Current Liabilities	271.33K	389.92K	242.22K	190.47K	179.87K	185.94K	418.88K	1.68M	3.53M	3.07M	1.33M
Total Current Liabilities	1.41M	1.53M	1.52M	1.14M	716.71K	745.47K	1.02M	4.53M	6.63M	5.22M	2.73M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	772.9K	933.36K	1.36M	1.29M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	718.99K	954.5K	536.84K	n/a	n/a	772.9K	933.36K	1.36M	1.29M
Total Liabilities	1.41M	1.53M	1.52M	1.14M	716.71K	745.47K	1.02M	5.31M	7.56M	6.58M	4.01M
Total Debt	n/a	n/a	559.92K	n/a	n/a	n/a	n/a	2.17M	2.15M	2.01M	1.85M
Common Stock	1.76K	1.69K	1.16K	1.16K	1.16K	1.16K	1.14K	636.00	636.00	636.00	636.00
Retained Earnings	-22.23M	-20.41M	-18.07M	-15.38M	-13.62M	-11.49M	-9.85M	-6.91M	-9.36M	-8.51M	-4.7M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	1.76M	3.07M	3.2M	5.54M	7.12M	9.04M	10.34M	-4.68M	-7.14M	-6.3M	-3.72M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a